Douglas Taylor, PhD, MS

Director, Biostatistics

Areas of expertise

  • Clinical trials
  • Experimental design
  • Statistical analysis

Projects & Resources

  • The goal of the Contraceptive Technology Innovation (CTI) Initiative is to develop new and strategically important contraceptives, through a strong focus on global partnerships, that ensures wide access to quality, affordable and acceptable products for those most in need.

  • The FEM-PrEP clinical trial was designed to assess whether a daily dose of the antiretroviral Truvada® is safe and effective at preventing HIV infection among women at high risk of HIV exposure.

Explore More Related to Douglas Taylor, PhD, MS